This will play a video - Standing healthcare professional in a white coat holding a stethoscope with arms crossed in a hospital setting

Evolutions in TAVR patient care educational videos

Heart valve experts discuss procedural techniques and clinical evidence relevant to your TAVR practice.

TAVR procedure and technique

TAVR with Evolut™ in 2021: contemporary techniques resulting in excellent patient outcomes - (24:28)

Drs. Harvey, Tchétché, and Yakubov discuss results from the Optimize PRO study, TVT-R PPI data, and expedited patient discharge.

Commissural alignment and coronary access strategies with the Evolut™ platform - (25:31)

Drs. Tang and Rogers discuss commissural alignment and the feasibility of post-TAVR coronary access with an Evolut valve.

A blueprint for bicuspid treatment: TAVR implant strategies for bicuspid patients - (31:48)

Drs. Forrest, Ramlawi, and Prof. Van Mieghem review recent bicuspid data, why the Evolut supra-annular valve should be considered for bicuspid patients, and discuss heart team considerations for selecting TAVR for this patient population.

Implantation considerations to minimize conduction disturbances in TAVR: the Latin American experience - (20:59)

Drs. Gada, Jaikel, and Mendiz talk about their centers’ experiences with the cusp overlap technique and discuss their outcomes.

Hemodynamics and durability

SURTAVI five-year results - (11:44)

Dr. Popma catches up with Dr. Reardon and Prof. Van Mieghem at TCT 2021 to discuss key results from the SURTAVI five-year late-breaking clinical trial.

Valve durability meta-analysis - (4:26)

Dr. Attizzani shares key learnings from his meta-analysis comparing self-expanding TAVs versus SAVR and balloon-expandable valves.

Durability matters for the initial valve selection - (19:32)

Drs. Forrest, O'Hair, and Prof. Sondergaard review recent data on predictors of hemodynamic valve deterioration (HVD), eight-year follow-up from the NOTION trial, and two-year follow-up from the Evolut Low Risk trial. Durability and the correlation between residual gradient and HVD are also discussed.

Valve hemodynamics: new data in women - (18:43)

Drs. Herrmann, Modine, and Prof. Pibarot discuss differences in flow and gradients between TAVR and SAVR in women with small aortic annuli from EuroPCR. The importance of avoiding patient-prosthesis mismatch is also discussed.

Decorative element

Build your knowledge

Medtronic Academy offers a wide range of resources for the Evolut TAVR platform

Decorative element

Hear from the experts

Get insights on aortic stenosis, guidelines, and TAVR from heart valve treatment experts.

Decorative element

See more evidence

Get details on clinical studies and real-world results supporting the Evolut platform.